A Case of Catastrophic Atypical Hemolytic Uremic Syndrome Unresponsive to Eculizumab and the use of Ravulizumab Off-label
Crossref DOI link: https://doi.org/10.29328/journal.jcn.1001113
Published Online: 2023-10-05
Update policy: https://doi.org/10.29328/crossmark-policy
Morales, Jorge Cabrera
Sias, Giuseppe
Manzoni, Marco
Loriga, Giacomina
License valid from 2023-10-05
